May 07, 2022
3 min watch
Save
VIDEO: ARMOR study shows MRSA resistance still significant
DENVER — The incidence of methicillin-resistant Staphylococcus aureus has gone down slightly but is still significant at 37%, Penny A. Asbell, MD, MBA, FARVO, said at the ARVO meeting.
The ARMOR surveillance study also showed that resistance to vancomycin and besifloxacin remains low, so they may be good choices for immediate treatment, she said.
Published by:
Sources/Disclosures
Collapse
Source:
Asbell P, et al. Antibiotic resistance among ocular staphylococcal pathogens: Longitudinal trends in the ARMOR study. Presented at: Association for Research in Vision and Ophthalmology meeting; May 1-4, 2022; Denver.
Disclosures:
Asbell reports no relevant financial disclosures.
Read more about